Top Story

VIDEO: PROMISE results on functional tests, CTA allow clinicians to feel 'comfortable' with resources

VIDEO: PROMISE results on functional tests, CTA allow clinicians to feel 'comfortable' with resources
April 19, 2015

SAN DIEGO — Paul L. Douglass, MD, chief of cardiology at the Atlanta Medical Center, Atlanta, Ga., discusses how the findings from the randomized PROMISE trial involving more than 10,000 patients will impact everyday patient care.

With no significant differences seen in all-cause mortality, CV hospitalization, MI or cardiac catheterization within 90 days when functional testing or CTA were used, Douglass said clinicians “know patients will be well-cared for and the outcomes very, very similar” no matter the resources available.

Michael Weber

REDUCE-HTN: REINFORCE study of renal denervation system underway

April 18, 2015
Boston Scientific has begun enrollment of the REDUCE-HTN: REINFORCE study, which will evaluate the efficacy and safety of renal denervation in patients with…
VIDEO: SAPIEN 3 valve yields low mortality, stroke rates in high, intermediate-risk patients Meeting News CoverageVideo

VIDEO: SAPIEN 3 valve yields low mortality, stroke rates in high, intermediate-risk patients

April 17, 2015
SAN DIEGO — In this video, Susheel Kodali, MD, of Columbia University Medical Center, New York-Presbyterian Hospital, discusses the 30-day results from the SAPIEN…
In the Journals

More adolescents with elevated LDLs would receive statins under adult treatment guidelines

April 17, 2015
Applying pediatric treatment guidelines for elevated low density lipoprotein cholesterol levels in young adults could result in a six-fold increase in the use of statin…
FDA News

FDA approves new generation of single-lead ICDs

April 17, 2015
Biotronik announced that it has received FDA approval for the company’s most recent generation of implantable cardioverter defibrillators. The approval was for the…
More News Headlines »
CME
Best of Lipid Forum III

Best of Lipid Forum III

This activity is supported by an educational grant from Amgen, Inc.

Appropriate therapies for various dyslipidemias remain a challenge for practitioners struggling to reduce residual risk…
More »
Meeting News Coverage Video
VIDEO: SAPIEN 3 valve yields low mortality, stroke rates in high, intermediate-risk patients

VIDEO: SAPIEN 3 valve yields low mortality, stroke rates in high, intermediate-risk patients

April 17, 2015
SAN DIEGO — In this video, Susheel Kodali, MD, of Columbia University Medical Center, New York-Presbyterian…
More »
CME
Obesity Consults: Volume 2, Number 2 Obesity Forum 2014 Highlights

Obesity Consults: Volume 2, Number 2
Obesity Forum 2014 Highlights

This activity is supported by educational grants from Takeda Pharmaceuticals International, Inc., US Region and Orexigen Therapeutics, Inc; Eisai, Inc.; Novo Nordisk; Vivus, Inc.

Management of obesity is complex, factoring in psychological, environmental, and physiologic causes. Treatment options…
More »
morganatic-roan